The Recall Desk
HighFDA (Food)·H-0623-2025·Announced 2025-10-01

Bulk blue razz gummies recalled over potential peanut protein cross-contact

Unlabelled bulk Blue Razz 20 mg gummies, lot 25JD082307A, are recalled because of potential peanut protein cross-contact. 19,810 gummies are affected.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers allergen mislabeling on common allergens; potential peanut protein cross-contact is not declared on the product.

Plain-English summary

Blue Razz 20 mg Gummies, supplied unlabelled in bulk to a private-label consignee and containing 20 mg CBD and 20 mg D9 THC per gummy, are being recalled. The affected product carries lot 25JD082307A with an expiry of 07/2027, printed on the bulk bag identifier adhesive. The recall covers 19,810 gummies distributed throughout the United States and in Australia, Germany, the United Kingdom, Malaysia and New Zealand.

The recall was issued because of potential peanut protein cross-contact. The FDA classified the action as Class II.

Businesses holding this lot should not use or resell it and should follow the recalling firm's instructions for return or disposal.

The recalled product

Product
Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use:
Manufacturer
Extract Labs, Inc.
Hazard
  • undeclared-allergen
  • peanuts
  • cross-contact
  • class-ii

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot: 25JD082307A EXP: 07/2027 Printed on bulk bag identifier adhesive

Distribution

Distribution scope not specified by the agency.